Clinical Outcomes And Patient Satisfaction Of Trifocal Intraocular Lens: Optiflex Trio

To assess the clinical outcomes and patient satisfaction of the trifocal intraocular lens (IOL) OPTIFLEX TRIO in patients who underwent cataract surgery.

Unidade Local de Saúde Almada Seixal, Almada, Portugal

Fifteen patients underwent bilateral OPTIFLEX TRIO IOL implantation. Best-corrected distance visual acuity (CDVA), uncorrected distance visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA) at 66 cm, uncorrected near visual acuity (UNVA) at 40 cm, and defocus curve were assessed. Patient-reported visual function was evaluated using the Catquest-9SF questionnaire, and the rate of spectacle independence was registered. The presence of photic phenomena was evaluated. Toric IOLs were not included. Statistical significance was set at p < 0.05.

The study included 30 eyes of 15 patients. The mean IOL power was +21.50 ± 4D (16.5–26D). Twenty-seven eyes (90.0%) were within ±0.5D of the predicted target. The postoperative mean refractive spherical equivalent (MRSE) was 0.08±0.40D. OPTIFLEX TRIO IOL provided a sustained visual acuity of 0.3 logMAR or better between +1.00D and -2.50D. Two patients (13.3%) reported mild halos and glare. Fourteen patients reported total spectacle independence and one reported the need for night driving.

This study shows that the OPTIFLEX TRIO trifocal IOL provides good visual outcomes for distance, intermediate, and near vision. However, these results are based on a three month follow-up period and long-term evaluation is needed to reinforce these data.